Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids Source: Eur Respir J 2010; 36: 503-508 Year: 2010
Therapeutic limitations of oral medications to normalize hemodynamics in patients with pulmonary artery hypertension. Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019
Effects of salmeterol on heart rate variability in patients with bronchial asthma and coronary artery disease Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
The cell haemostasis changes under the glucocorticoid therapy influence in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006
Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Effects of bronchial artery embolization in hemoptysis patients, and factors influencing relapse Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005
The glucocorticoid therapy influence on the lung microcirculation in patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 353s Year: 2005
Differences of systemic arteries mechanical properties during remission and exacerbation of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 552s Year: 2007
The influence of different ways of steroid administration on the hemostasis parameters of bronchial asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 421s Year: 2003
Short and long-term effects of pulmonary endarterectomy on ventilatory responses and exercise capacity of patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – The lungs and the heart during exercise Year: 2017
Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids Source: Eur Respir J 2002; 20: Suppl. 38, 480s Year: 2002
The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
The comparison of carotid artery intima media thickness and inflamatory markers in patients with COPD Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008
A case-control study on direct oral anticoagulants versus warfarin for acute pulmonary embolism in obese patients Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
Analysis of pulmonary functions in patients with mitral stenosis in various stages of disease: effects of inhaled corticosteroid on pulmonary functions in mitral stenosis Source: Eur Respir J 2001; 18: Suppl. 33, 380s Year: 2001
The therapeutic effects of zafirlukast on COPD induced pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
The effects of external nasal dilator strips on exercise tolerance in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 329s Year: 2003
Effect of oral and inhalation corticosteroids on osseous tissue condition for patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002
Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010